Stockreport

New Data From Hadassah Medical Center Lab Show Can-Fite’s Namodenoson Induces Weight Loss 

Can-Fite Biopharma Ltd American Depositary Shares, each representing two (2) Ordinary Shares  (CANF) 
NASDAQ:AMEX Investor Relations: ir.canfite.com
PDF Findings combined with Namodenoson’s good safety profile support its potential utilization as an anti-obesity drugPCT Patent application filed for anti-obesity indicatio [Read more]